|
Contents |
|
|
|
Etiology & Pathogenesis
|
|
Treatment
|
|
|
Etiology & Pathogenesis
|
|
|
|
|
Cankovic
M, Mikkelsen T, Rosenblum ML, Zarbo RJ.
A simplified laboratory validated assay for MGMT promoter hypermethylation
analysis of glioma specimens from formalin-fixed paraffin-embedded tissue.
Lab
Invest. 2007 Apr;87(4):392-7. Epub 2007 Jan 29.
PMID: 17260000 [PubMed - indexed for MEDLINE]
|
|
|
Khwaja
FW, Reed MS, Olson JJ, Schmotzer BJ, Gillespie GY, Guha A, Groves MD, Kesari
S, Pohl J, Meir EG.
Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of
astrocytoma patients.
J Proteome Res.
2007 Feb;6(2):559-70.
PMID: 17269713 [PubMed - indexed for MEDLINE]
|
|
*
|
Khwaja
FW, Nolen JD, Mendrinos SE, Lewis MM, Olson JJ, Pohl J, Van Meir EG, Ritchie
JC, Brat DJ.
Proteomic analysis of cerebrospinal fluid discriminates malignant and
nonmalignant disease of the central nervous system and identifies specific
protein markers.
Proteomics. 2006
Dec;6(23):6277-87.
PMID: 17078017 [PubMed - indexed for MEDLINE]
|
|
|
Nakada
M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME.
Molecular targets of glioma invasion.
Cell
Mol Life Sci. 2007 Feb;64(4):458-78. Review.
PMID: 17260089 [PubMed - indexed for MEDLINE]
|
|
|
Zeng
WF, Navaratne K, Prayson RA, Weil RJ.
Aurora B expression correlates with aggressive behaviour in glioblastoma
multiforme.
J Clin Pathol.
2007 Feb;60(2):218-21.
PMID: 17264249 [PubMed - indexed for MEDLINE]
|
|
|
|
|
|
Treatment
|
|
|
|
|
Lawson
HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, Weingart J, Kleinberg
L, Brem H.
Interstitial chemotherapy for malignant gliomas: the Johns Hopkins
experience.
J Neurooncol.
2007 May;83(1):61-70. Epub 2006 Dec 14.
PMID: 17171441 [PubMed - in process]
|
|
|
Nalabothula
N, Lakka SS, Dinh DH, Gujrati M, Olivero WC, Rao JS.
Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and
induces glioma cell death.
Int J Oncol.
2007 Mar;30(3):669-78.
PMID: 17273768 [PubMed - indexed for MEDLINE]
|
|
|
Weingart
J, Grossman SA, Carson KA, Fisher JD, Delaney SM, Rosenblum ML, Olivi A,
Judy K, Tatter SB, Dolan ME.
Phase I trial of polifeprosan 20 with carmustine implant plus continuous
infusion of intravenous O6-benzylguanine in adults with recurrent malignant
glioma: new approaches to brain tumor therapy CNS consortium trial.
J
Clin Oncol. 2007 Feb 1;25(4):399-404.
PMID: 17264335 [PubMed - indexed for MEDLINE]
|
bottom
|